These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27896110)

  • 1. Whole exome sequencing reveals compound heterozygous mutations in
    Sremba LJ; Chang RC; Elbalalesy NM; Cambray-Forker EJ; Abdenur JE
    Mol Genet Metab Rep; 2014; 1():368-372. PubMed ID: 27896110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease?
    Kamaşak T; Havalı C; İnce H; Eyüboğlu İ; Çebi AH; Sahin S; Cansu A; Aydin K
    Eur J Paediatr Neurol; 2018 Nov; 22(6):1139-1149. PubMed ID: 30054086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment.
    Algahtani H; Ghamdi S; Shirah B; Alharbi B; Algahtani R; Bazaid A
    Neurol Res; 2017 Feb; 39(2):117-125. PubMed ID: 27905264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-induced upregulation of SLC19A3 is impaired in biotin-thiamine-responsive basal ganglia disease.
    Schänzer A; Döring B; Ondrouschek M; Goos S; Garvalov BK; Geyer J; Acker T; Neubauer B; Hahn A
    Brain Pathol; 2014 Apr; 24(3):270-9. PubMed ID: 24372704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy.
    Flønes I; Sztromwasser P; Haugarvoll K; Dölle C; Lykouri M; Schwarzlmüller T; Jonassen I; Miletic H; Johansson S; Knappskog PM; Bindoff LA; Tzoulis C
    PLoS One; 2016; 11(2):e0149055. PubMed ID: 26863430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound heterozygous
    Whitford W; Hawkins I; Glamuzina E; Wilson F; Marshall A; Ashton F; Love DR; Taylor J; Hill R; Lehnert K; Snell RG; Jacobsen JC
    Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 28696212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotin-Responsive Basal Ganglia Disease: Treatable Metabolic Disorder with SLC19A3 Mutation Presenting as Rapidly Progressive Dementia.
    Oommen AT; Polavarapu K; Christopher R; Netravathi M
    Neurol India; 2022; 70(2):733-736. PubMed ID: 35532649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early treatment of biotin-thiamine-responsive basal ganglia disease improves the prognosis.
    Wesół-Kucharska D; Greczan M; Kaczor M; Pajdowska M; Piekutowska-Abramczuk D; Ciara E; Halat-Wolska P; Kowalski P; Jurkiewicz E; Rokicki D
    Mol Genet Metab Rep; 2021 Dec; 29():100801. PubMed ID: 34631424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the caudate nucleus: Early atypical neuroimaging findings in biotin-thiamine- responsive basal ganglia disease.
    Alsini H; Alnozha A; Asmat Z; Hundallah K; Alfadhel M; Tabarki B
    Brain Dev; 2022 Oct; 44(9):618-622. PubMed ID: 35811190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatable Leigh-like encephalopathy presenting in adolescence.
    Fassone E; Wedatilake Y; DeVile CJ; Chong WK; Carr LJ; Rahman S
    BMJ Case Rep; 2013 Oct; 2013():200838. PubMed ID: 24099834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotin-Thiamine Responsive Encephalopathy: Report of an Egyptian Family with a Novel
    Savasta S; Bassanese F; Buschini C; Foiadelli T; Trabatti C; Efthymiou S; Salpietro V; Houlden H; Simoncelli A; Marseglia GL
    J Pediatr Genet; 2019 Jun; 8(2):100-108. PubMed ID: 31061755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: biotin-thiamine-responsive basal ganglia disease with severe subdural hematoma on magnetic resonance imaging.
    Huang H; Jiang H; Yang M; Gao Y; Cao L
    Int J Neurosci; 2024 Jun; 134(2):184-192. PubMed ID: 35775132
    [No Abstract]   [Full Text] [Related]  

  • 13. SLC19A3 Gene Defects Sorting the Phenotype and Acronyms: Review.
    Alfadhel M; Tabarki B
    Neuropediatrics; 2018 Apr; 49(2):83-92. PubMed ID: 28962040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing.
    Kohrogi K; Imagawa E; Muto Y; Hirai K; Migita M; Mitsubuchi H; Miyake N; Matsumoto N; Nakamura K; Endo F
    J Hum Genet; 2015 Jul; 60(7):381-5. PubMed ID: 25876998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotin Thiamin Responsive Basal Ganglia Disease in Siblings.
    Gowda VK; Srinivasan VM; Bhat M; Benakappa N
    Indian J Pediatr; 2018 Feb; 85(2):155-157. PubMed ID: 29101630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome.
    Gerards M; Kamps R; van Oevelen J; Boesten I; Jongen E; de Koning B; Scholte HR; de Angst I; Schoonderwoerd K; Sefiani A; Ratbi I; Coppieters W; Karim L; de Coo R; van den Bosch B; Smeets H
    Brain; 2013 Mar; 136(Pt 3):882-90. PubMed ID: 23423671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathological characteristics of the brain in two patients with SLC19A3 mutations related to the biotin-thiamine-responsive basal ganglia disease.
    Pronicki M; Piekutowska-Abramczuk D; Jurkiewicz E; Rokicki D; Ciara E; Trubicka J; Iwanicka-Pronicka K; Pajdowska M; Migdał M; Grajkowska WA
    Folia Neuropathol; 2017; 55(2):146-153. PubMed ID: 28677371
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotin-thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next-generation sequencing data.
    Ferreira CR; Whitehead MT; Leon E
    Am J Med Genet A; 2017 Jun; 173(6):1502-1513. PubMed ID: 28402605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal form of biotin-thiamine-responsive basal ganglia disease. Clues to diagnosis.
    Değerliyurt A; Gündüz M; Ceylaner S; Ünal Ö; Ünal S
    Turk J Pediatr; 2019; 61(2):261-266. PubMed ID: 31951338
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.